Imclone Systems’ 2Q Profit Drops (AP via Yahoo! Finance)

Biotechnology company Imclone Systems Inc. said Tuesday second-quarter profit fell 14 percent on basically flat revenue as U.S. sales of cancer drug Erbitux fell.

Original post by Lyle

This entry was posted on Tuesday, July 31st, 2007 at 6:55 am and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.